Insider transactions

EDGAR

ABVC BioPharma, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-16.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

This issuer has insider filings in the store, but no transaction in this window or code group.

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 7,211 filings read, the latest filed 2026-11-13. Prior quarter ending 2026-06-30: 9,150 filings read.

Showing 1–11 of 11

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
VANGUARD CAPITAL MANAGEMENT LLC 569,150 SH603,299 dollarsHigher by 194,651 Prior quarter: 374,499Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager236,734 SH250,987 dollarsHigher by 8,692 Prior quarter: 228,042Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
UBS Group AG Partly reported under another manager139,178 SH147,529 dollarsHigher by 105,055 Prior quarter: 34,123Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
VANGUARD FIDUCIARY TRUST CO 97,363 SH103,205 dollarsUnchanged Prior quarter: 97,363Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
STATE STREET CORP Partly reported under another manager91,300 SH96,778 dollarsHigher by 18,500 Prior quarter: 72,800Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
BlackRock, Inc. Partly reported under another manager56,442 SH59,829 dollarsUnchanged Prior quarter: 56,442Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
PANAGORA ASSET MANAGEMENT INC 36,682 SH38,883 dollarsUnchanged Prior quarter: 36,682Open filing 0000883677-26-000011 Filed 2026-11-12 Dispute this row
Squarepoint Ops LLC Partly reported under another manager11,390 SH12,073 dollarsNot in the prior quarter’s filings read Open filing 0001642575-26-000012 Filed 2026-11-09 Dispute this row
BARCLAYS PLC Partly reported under another manager2 SH2 dollarsNot in the prior quarter’s filings read Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row
SBI Securities Co., Ltd. 1 SH1 dollarsNot in the prior quarter’s filings read Open filing 0001851815-26-000004 Filed 2026-10-22 Dispute this row
Caitong International Asset Management Co., Ltd 1 SH1 dollarsLower by 5 Prior quarter: 6Open filing 0001628280-26-068135 Filed 2026-10-29 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • CITADEL ADVISORS LLC 72,091 SH
  • NORTHERN TRUST CORP 48,643 SH
  • XTX Topco Ltd 48,276 SH
  • JANE STREET GROUP, LLC 20,059 SH
  • CITADEL ADVISORS LLC 11,600 SH
  • CITIGROUP INC 540 SH
  • LifeSteps Financial, Inc. 300 SH
  • ROYAL BANK OF CANADA 17 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Eugene Jiang Common Stock, par value $0.001 per share18.50131,159.0007/10/2025 Filed 2025-07-15SCHEDULE 13D/AAmendment 1Open filing 0001213900-25-064283 Dispute this row
Lind Global Fund II LP Common Stock, par value $0.001 per share3.2557,14306/30/2025 Filed 2025-08-13SCHEDULE 13G/AAmendment 4Open filing 0000929638-25-003007 Dispute this row
Lind Global Partners II LLC Common Stock, par value $0.001 per share3.2557,14306/30/2025 Filed 2025-08-13SCHEDULE 13G/AAmendment 4Open filing 0000929638-25-003007 Dispute this row
EASTON JEFF Common Stock, par value $0.001 per share3.2557,14306/30/2025 Filed 2025-08-13SCHEDULE 13G/AAmendment 4Open filing 0000929638-25-003007 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,045,099 filings read, dated 2004-06-14 to 2026-11-13: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
20151
2016204,322
2017202,494
2018202,048
2019193,638
2020144,184
2021224,474
202240,015
2023199,811
2024138,788
2025235,520
2026254,026

Filings made before the SEC required XML are listed, not extracted.

Back to ABVC BioPharma, Inc.